Two months after COVID-19 vaccines were rolled out to the U.S. public, a statistically significant vaccine safety signal for myocarditis in males ages 8 to 21 appeared in the Centers for Disease Control’s (CDC) Vaccine Adverse Event Reporting System (VAERS) — but CDC officials waited another three months before alerting the public, according to a new study.
The White House amplified multiple grocery stores and pharmacy chains’ offers to provide $20 vouchers for Americans who get another dose of the COVID-19 vaccine.
U.S. business activity contracted for the fourth straight month in October, and the economic downturn “gathered significant momentum,” S&P Global said on Monday, while the White House touted low unemployment rates and credited President Joe Biden’s economic agenda for a “historically strong” economic recovery.
The Republican National Committee (RNC) filed a lawsuit against Google on Friday, accusing the tech giant of sending its emails straight to users’ spam folders.
The effectiveness of the Pfizer and AstraZeneca COVID-19 vaccines turns negative against severe COVID-19 months after administration, according to a new study.
Democrats are increasingly concerned that Florida, once the nation’s premier swing state, may slip away this fall and beyond as emboldened Republicans capitalize on divisive cultural issues and population shifts in crucial contests for governor and the U.S. Senate.